Powered Bone Marrow Aspiration and Core Biopsy System Compared to Manual Devices
This study has been completed.
Sponsor:
Vidacare Corporation
Information provided by:
Vidacare Corporation
ClinicalTrials.gov Identifier:
NCT01312519
First received: November 3, 2010
Last updated: March 8, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a randomized study evaluating use of a powered bone marrow biopsy and aspiration system (OnControl by Vidacare) compared to traditional manual devices. The hypothesis is that the powered system will reduce the level of patient pain during the aspiration and core biopsy procedures and the amount of time needed to perform the procedures.
| Condition | Intervention |
|---|---|
|
Bone Marrow Biopsy Procedures |
Device: OnControl Bone Marrow Biopsy and Aspiration System Device: Manual bone marrow sampling device |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | A Trial of the Vidacare Powered Bone Marrow Aspiration and Core Biopsy Systems (OnControl by Vidacare) Compared to Traditional Manual Devices |
Further study details as provided by Vidacare Corporation:
Primary Outcome Measures:
- subject reported level of pain during procedure [ Time Frame: Patient is only followed for the time it takes to perform the bone marrow procedure (less than 24 hrs). No additonal follow up is required. ] [ Designated as safety issue: No ]Subjects were asked to rate the level of pain they expereinced during the procedure at two specific time points: 1)for needle insertion, following penetration of the cortex, and 2)following removal of the needle from the patient for an overall pain score.
Secondary Outcome Measures:
- Time necessary to perform the bone marrow procedure [ Time Frame: Patient is followed only for the time necessary to perform the bone marrow procedure (less than 24 hrs). No additional patient follow up is required. ] [ Designated as safety issue: No ]The time necessary to perform the procedure was measured as follows: Time started once the needle and skin came into contact and time stopped once the sample was collected and the needle was removed from the patient.
| Enrollment: | 50 |
| Study Start Date: | January 2010 |
| Study Completion Date: | August 2010 |
| Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Manual bone marrow sampling device
hollow needle with a t-shaped handle manually pushed into the bone for the purpose of bone marrow aspiration and core biopsy collection.
|
Device: Manual bone marrow sampling device
Hollow needle with a t-shaped handle that is pushed into the bone for the purpose of collecting bone marrow aspiration and core biopsy samples.
Other Names:
|
|
Active Comparator: OnControl Bone Marrow System
Battery powered device used for insertion of a single lumen catheter into the intraosseous space of the adult iliac crest.
|
Device: OnControl Bone Marrow Biopsy and Aspiration System
Battery powered device used for insertion of a single lumen catheter into the intraosseous space of the adult iliac crest for the purpose of aspiration and core biopsy collection.
Other Names:
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Adults over the age of 18
- Patients that require core biopsy alone, or core biopsy and bone marrow aspiration
Exclusion Criteria:
- Imprisoned
- Pregnant
- Cognitively impaired
- Requiring english language translation other than Spanish
- Patients with one or more conditions precluding bone marrow core biopsy
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01312519
Locations
| United States, Texas | |
| Cancer Therapy and Research Center | |
| San Antonio, Texas, United States, 78229 | |
| Spain | |
| Hospital General Universitario Gregorio Maranon | |
| Madrid, Spain, 28007 | |
Sponsors and Collaborators
Vidacare Corporation
Investigators
| Study Director: | Thomas Philbeck, PhD | Vidacare Corporation |
More Information
No publications provided
| Responsible Party: | Thomas Phibeck/ Director of Science and Clinical, Vidacare Corporation |
| ClinicalTrials.gov Identifier: | NCT01312519 History of Changes |
| Other Study ID Numbers: | 2007-04 |
| Study First Received: | November 3, 2010 |
| Last Updated: | March 8, 2011 |
| Health Authority: | United States: Institutional Review Board Spain: Ethics Committee |
Keywords provided by Vidacare Corporation:
|
Bone marrow biopsy of iliac crest |
ClinicalTrials.gov processed this record on May 16, 2013